These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17031535)

  • 1. Reverse fingerprinting, similarity searching by group fusion and fingerprint bit importance.
    Williams C
    Mol Divers; 2006 Aug; 10(3):311-32. PubMed ID: 17031535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similarity-based virtual screening using 2D fingerprints.
    Willett P
    Drug Discov Today; 2006 Dec; 11(23-24):1046-53. PubMed ID: 17129822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anatomy of fingerprint search calculations on structurally diverse sets of active compounds.
    Godden JW; Stahura FL; Bajorath J
    J Chem Inf Model; 2005; 45(6):1812-9. PubMed ID: 16309288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction and recombination of fingerprints of different design increase compound recall and the structural diversity of hits.
    Nisius B; Bajorath J
    Chem Biol Drug Des; 2010 Feb; 75(2):152-60. PubMed ID: 20028390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale similarity search profiling of ChEMBL compound data sets.
    Heikamp K; Bajorath J
    J Chem Inf Model; 2011 Aug; 51(8):1831-9. PubMed ID: 21728295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 2D fingerprint methods for multiple-template similarity searching on compound activity classes of increasing structural diversity.
    Tovar A; Eckert H; Bajorath J
    ChemMedChem; 2007 Feb; 2(2):208-17. PubMed ID: 17143917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Random reduction in fingerprint bit density improves compound recall in search calculations using complex reference molecules.
    Wang Y; Geppert H; Bajorath J
    Chem Biol Drug Des; 2008 Jun; 71(6):511-7. PubMed ID: 18466274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and evaluation of a novel class-directed 2D fingerprint to search for structurally diverse active compounds.
    Eckert H; Bajorath J
    J Chem Inf Model; 2006; 46(6):2515-26. PubMed ID: 17125192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modeling studies of pyridopurinone derivatives--potential phosphodiesterase 5 inhibitors.
    Srivani P; Srinivas E; Raghu R; Sastry GN
    J Mol Graph Model; 2007 Jul; 26(1):378-90. PubMed ID: 17307372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bit silencing in fingerprints enables the derivation of compound class-directed similarity metrics.
    Wang Y; Bajorath J
    J Chem Inf Model; 2008 Sep; 48(9):1754-9. PubMed ID: 18698839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 46-amino acid segment in phosphodiesterase-5 GAF-B domain provides for high vardenafil potency over sildenafil and tadalafil and is involved in phosphodiesterase-5 dimerization.
    Blount MA; Zoraghi R; Ke H; Bessay EP; Corbin JD; Francis SH
    Mol Pharmacol; 2006 Nov; 70(5):1822-31. PubMed ID: 16926278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a fingerprint reduction approach for Bayesian similarity searching based on Kullback-Leibler divergence analysis.
    Nisius B; Vogt M; Bajorath J
    J Chem Inf Model; 2009 Jun; 49(6):1347-58. PubMed ID: 19480403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shannon entropy-based fingerprint similarity search strategy.
    Wang Y; Geppert H; Bajorath J
    J Chem Inf Model; 2009 Jul; 49(7):1687-91. PubMed ID: 19583222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How do 2D fingerprints detect structurally diverse active compounds? Revealing compound subset-specific fingerprint features through systematic selection.
    Heikamp K; Bajorath J
    J Chem Inf Model; 2011 Sep; 51(9):2254-65. PubMed ID: 21793563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of molecular fingerprint similarity search in virtual screening.
    Muegge I; Mukherjee P
    Expert Opin Drug Discov; 2016; 11(2):137-48. PubMed ID: 26558489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of data fusion methods in virtual screening: theoretical model.
    Whittle M; Gillet VJ; Willett P; Loesel J
    J Chem Inf Model; 2006; 46(6):2193-205. PubMed ID: 17125164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rendering conventional molecular fingerprints for virtual screening independent of molecular complexity and size effects.
    Nisius B; Bajorath J
    ChemMedChem; 2010 Jun; 5(6):859-68. PubMed ID: 20425878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the performance of fingerprint similarity searching.
    Vogt M; Bajorath J
    Methods Mol Biol; 2011; 672():159-73. PubMed ID: 20838968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A similarity-based data-fusion approach to the visual characterization and comparison of compound databases.
    Medina-Franco JL; Maggiora GM; Giulianotti MA; Pinilla C; Houghten RA
    Chem Biol Drug Des; 2007 Nov; 70(5):393-412. PubMed ID: 17927720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of topological descriptors for similarity-based virtual screening using multiple bioactive reference structures.
    Hert J; Willett P; Wilton DJ; Acklin P; Azzaoui K; Jacoby E; Schuffenhauer A
    Org Biomol Chem; 2004 Nov; 2(22):3256-66. PubMed ID: 15534703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.